Company research / LFMD

LifeMD, Inc. (LFMD)

Also trades as LFMDP. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

CIK 0000948320 · Nasdaq · Services-Offices & Clinics of Doctors of Medicine

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, LifeMD, Inc. reported revenue of $194.06M. Revenue grew 25.3% from the prior annual period.

Key ratios (year ended 2025-12-31)

85.7%
Gross margin
-4.0%
Operating margin
7.4%
Net margin
62.0%
Return on year-end equity
25.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 1-for-5, first reflected in a filing dated 2020-11-16. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenuen/a$194.06M$154.82M$152.55M$119.03M$92.88M$37.29M$12.47M$8.32M$3.68M$5.24M
Cost of Revenuen/a$27.71M$21.44M$18.90M$18.67M$18.00M$8.86M$2.53M$2.00M$1.02M$1.95M
Gross Profitn/a$166.34M$133.38M$133.65M$100.37M$74.88M$28.43M$9.94M$6.33M$2.66M$3.29M
Operating Incomen/a-$7.67M-$20.40M-$14.49M-$43.45M-$54.30M-$57.82M-$2.89M-$2.06M-$1.23M-$1.17M
Net Income$201.0K$14.35M-$21.41M-$20.60M-$45.54M-$60.90M-$58.65M-$3.14M-$1.24M-$1.21M-$1.11M
EPS (Diluted)n/a$0.25-$0.60n/an/an/an/an/an/a-$0.03-$0.03
Total Assets$59.89M$70.41M$76.10M$58.48M$25.67M$49.92M$13.40M$3.45M$2.62M$1.26M$789.8K
Total Liabilities$51.93M$47.25M$83.65M$52.91M$32.97M$24.10M$14.22M$4.58M$1.80M$641.0Kn/a
Shareholders' Equity$7.97M$23.16M-$9.08M$3.51M-$11.40M$22.74M-$2.30M-$988.2K$897.7K$881.9K-$355.2K
Cash & Equivalentsn/an/a$35.00M$33.15M$3.96M$41.33M$9.18M$1.11M$180.1K$141.4K$182.6K
Operating Cash Flow-$9.91M$8.28M$17.51M$8.82M-$22.94M-$33.09M-$12.13M$251.4K-$905.5K-$817.2K-$407.9K
Capital Expendituresn/a$1.87M$1.46M$203.8K$366.6K$247.4Kn/an/an/an/an/a
Free Cash Flown/a$6.41M$16.05M$8.62M-$23.30M-$33.33Mn/an/an/an/an/a
Share Repurchasesn/a$270.0Kn/an/an/an/an/an/an/a$76.6Kn/a
Dividends Paid$3.11M$3.11M$3.11M$3.11M$3.11M$871.5Kn/an/an/an/an/a
Shares Outstanding47.82M46.66M42.19M38.26M31.45M30.60M23.33M10.58M45.27M43.98M35.25M
Weighted Average Diluted Sharesn/a45.13M41.20M33.91M30.98M27.01M14.28M9.90M44.19M41.74M33.48M
EPS (Basic)n/a$0.25-$0.60n/an/an/an/an/an/a-$0.03-$0.03

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView